Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectKinase Inhibitors: Global Markets -- Focus on the U.S.
This report explores present and future strategies within the kinase inhibitors market with a focus on the U.S. Includes forecasts through 2016.
Kinase Inhibitors: Global Markets -- Focus on Europe
This report explores present and future strategies within the kinase inhibitors market with a focus on Europe. Includes forecasts through 2016.
Global Markets for Enzyme Inhibitors -- Focus on Europe
A detailed analysis of the enzyme inhibitors industry structure has been conducted. This report focuses on the European markets and sales figures are estimated for the five-year forecast period of this report, from 2011 to 2016.
Global Markets for Enzyme Inhibitors -- Focus on Emerging Market...
A detailed analysis of the enzyme inhibitors industry structure has been conducted. This report focuses on Emerging Markets and sales figures are estimated for the five-year forecast period of this report, from 2011 to 2016.
Global Markets for Enzyme Inhibitors -- Focus on the US
A detailed analysis of the enzyme inhibitors industry structure has been conducted. This report focuses on the US markets and sales figures are estimated for the five-year forecast period of this report, from 2011 to 2016.
Global Markets for Chiral Technology -- Focus on Emerging Markets
The scope of this study encompasses the chiral markets with their usage in the pharmaceutical, biotechnical and agrochemical markets. This report focuses on emerging markets and includes forecasts through 2016.
Global Markets for Chiral Technology -- Focus on Europe
The scope of this study encompasses the chiral markets with their usage in the pharmaceutical, biotechnical and agrochemical markets. This report focuses on Europe and includes forecasts through 2016.
Global Markets for Chiral Technology -- Focus on the U.S.
The scope of this study encompasses the chiral markets with their usage in the pharmaceutical, biotechnical and agrochemical markets. This report focuses on the US and includes forecasts through 2016.
Global Markets for Chiral Technology
The global chiral technology market was worth nearly $5.3 billion in 2011. This market is expected to increase at a CAGR of 6.5% from 2011 to 2016 and will approach $7.2 billion by the end of the forecast period.
Global Markets for Media, Sera and Reagents in Biotechnology -- F...
An overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. Focuses on the emerging markets and includes forecasts through 2016.
Global Markets for Media, Sera and Reagents in Biotechnology -- F...
An overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. Focuses on the US and includes forecasts through 2016.
Global Markets for Media, Sera and Reagents in Biotechnology -- F...
An overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. Focuses on Asia and includes forecasts through 2016.
Global Markets for Media, Sera and Reagents in Biotechnology -- F...
An overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. Focuses on Europe and includes forecasts through 2016.
Global Markets for Enzymes in Industrial Applications -- Focus on...
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for industrial enzymes - with a focus on Emerging Markets. Includes forecasts through 2016.
Global Markets for Enzymes in Industrial Applications -- Focus on...
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for industrial enzymes - with a focus on Asia. Includes forecasts through 2016.
Global Markets for Enzymes in Industrial Applications -- Focus on...
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for industrial enzymes - with a focus on Europe. Includes forecasts through 2016.
Global Markets for Enzymes in Industrial Applications -- Focus on...
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for industrial enzymes - with a focus on North America. Includes forecasts through 2016.
Labeling and Linkage Agents for Immunoassays and Gene Probes
The market for immunoagents, probes and molecular diagnostics was $29.6 billion in 2010. This market is projected to be $33.5 billion in 2011 and will increase up to $60.3 billion by 2016 at a compound annual growth rate (CAGR) of 12.5%.
Medical Enzymes: Technologies and Global Markets
The market for enzymes in medicine is growing. The global market for medical enzymes is estimated at $6 billion in 2010. The market is growing at a compound annual growth rate (CAGR) of 3.9%, to reach $7.2 billion in 2015.
Stem Cell Therapeutics for Oncology: Technologies and Global Mark...
The global stem cell anticancer therapeutics market was valued at $859 million in 2010. This market is expected to increase at an 11.3% compound annual growth rate (CAGR) to reach nearly $1.5 billion in 2015.
Therapeutics for Immune System Disorders
In 2010, the global market for drugs for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.
Biotechnologies for Medical Applications: Global Markets
The report addresses the global market for biotechnologies used in medical and healthcare-related applications during the period from 2009 through 2015.
New Developments in Treating Genetic Disorders: The Global Market
The goal of the study is to provide an overview of a range of genetic disorders, both mutation and chromosomal in nature, and provide market summaries and new research and developments. The market is discussed for the 2009 year and forecasts are provided through 2014. Product descriptions, discussions of new research, and company profiles are also provided.
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics an...
BCC's goal for this study was to examine the status of commercial epigenomics technologies and products and assess their worldwide growth potential over a 5-year period from 2009 to 2014. We analyzed the four important market segments for epigenomics: research tools, diagnostics, therapeutics, and assays for cellular therapies.
Therapeutic Vaccines: The Global Market
This BCC market research report determines the current status of the therapeutic vaccines industry and assess its growth potential over a 5-year period from 2010 to 2015
Bioinformatics: Technologies and Global Markets
This report provides an overview of the global bioinformatics technologies market and analyzes market trends. It includes global revenue ($ million) for the base year (2024), estimated data for 2025, and forecast data for 2026 to 2030. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also discusses emerging technologies related to the market.
Biologic Therapies for Wound Care: Technologies and Global Markets
This report provides an overview of the global wound care biologics market and analyzes market trends. It includes global revenue ($ million) for the base year (2024), estimated data for 2025, and forecast data for 2026 to 2030. The market is segmented based on product type, composition, material, tissue source, application, end user, and region.
Mobile Apps for DNA Sequencing: Global Markets
This report provides comprehensive analysis of the mobile DNA sequencing market, focusing on the key driving trends and challenges. It includes in-depth value chain and supply chain analysis, as well as a detailed view of the industry ecosystem.
Current Bioprinting Prospects and Future Innovations: Global Markets
This report provides an overview of the global 3D bioprinting market and analyzes market trends. It includes global revenue for the base year 2025, estimated data for 2026, and forecast data for 2026 to 2031. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape.
The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
This report analyzes the current and future potential of the U.S. biodefense-related rapid pathogen identification and treatment market, covering market trends, regulatory developments, technological advancements, and competitive dynamics. It examines market segmentation by detection devices and sensors, testing type, application, and end user, including government agencies, hospitals, research institutes, and pharmaceutical companies. The study also highlights emerging technologies, key growth opportunities, and leading market players, while providing market forecasts through 2030.
Global HLA Typing for Transplant Market
This report analyzes the global HLA typing for transplant market, covering market size, growth trends, industry dynamics, emerging technologies, and competitive developments. The market is segmented by product and service type, technology, application, end user, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study includes insights into key applications such as solid organ and hematopoietic stem cell transplants, along with profiles of leading companies and forecasts through 2030.
Global Gene Transfer Technologies Market
This report provides an overview of the global gene transfer technologies market, analyzing key market trends, growth drivers, challenges, and emerging technologies. The market is segmented by vector type, application, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study also evaluates the impact of PESTEL factors and Porter’s Five Forces, while offering strategic insights into the competitive landscape and profiles of leading companies. Market forecasts are provided through 2030.
Single-use Technologies for Biopharmaceuticals: Global Markets
This report provides an overview of the global single-use technologies for biopharmaceuticals market and analyzes market trends. It includes global revenue ($ million) for the base year data of 2025 and estimated data for the forecast period from 2026 through 2031.
Next-Generation Cancer Diagnostics: Technologies and Global Markets
This report provides an overview of the global next-generation cancer diagnostics market and analyzes market trends. It includes global revenue ($ million) for the base year data of 2025 and estimated data for the forecast period from 2026 through 2031.
Agricultural Biotechnology: Emerging Technologies and Global Markets
The report provides an analysis of the global agricultural biotechnology market, using 2025 as the base year, 2026 as the estimate, and forecasts through 2031 with CAGR projections. It covers market trends, competitive landscape, drivers, restraints, opportunities, and emerging technologies, along with rankings of key players. The market is segmented by product type, end use, and region.
Biologics Development and Manufacturing Testing: Technologies and Global Markets
This report provides an overview of the global biologics testing market, covering key market trends, growth drivers, challenges, and emerging technologies. It analyzes the market by application, test type, technology, and region, while also examining the competitive landscape and profiling leading companies, with forecasts from 2027 to 2031.
Microbial Products: Technologies Applications and Global Markets
This report provides an overview of the global microbial products market, including key technologies, applications, market trends, and growth opportunities. It analyzes the market by product type, technology, end user, and region, while highlighting emerging technologies, patent activity, competitive dynamics, and profiles of leading companies, with forecasts from 2026 to 2031.